Contribution of Diffusion Tensor MR Imaging in Detecting Cerebral Microstructural Changes in Adults with Neurofibromatosis Type 1

Materials and Methods

Subjects.

In this context, we refer to subjects affected by NF-1 as “patients.” The patients participating in this study were known previously to our NF clinic and were recruited through personal contacts to the Swiss Neurofibromatosis Organization. They fulfilled the diagnostic criteria for NF-1 based on a National Institutes of Health 1988 Consensus⁵ and were not known to suffer from obvious pathologic brain conditions (eg, brain tumor, epilepsy). There were 10 unrelated patients (4 women and 6 men), ranging in age from 18 to 36 years (mean age ± SD: 25.8 ± 5.4 years). We focused on this age group because no myelin remodeling (NBO) is to be expected at this age.^8,14,15

Two patients (P2, P6) attended special schools because of their marked and severe learning difficulties; the schooling of the other patients was age-appropriate. The professional training is as follows: P1 and P4 obtained a university degree. Six patients are in full-time employment and self-sufficient, 3 of them (P5, P9, P10) were in 3-year vocational training, and 3 (P3, P7, P8) in 2-year vocational training. P2 works part-time (manual work), whereas P6 lives in an institution for handicapped people. Ten age-matched healthy volunteers (4 women, 6 men; age range, 20–36 years; mean age ± SD, 26.3 ± 4.6 years) served as control subjects.

The study was carried out according to the ethic guidelines of the hospital as defined by the Helsinki Declaration. Written informed consent was obtained from all subjects or from their parents if appropriate.

MR measurements were carried out on a 1.5T whole-body MR system. Standard diagnostic T1-weighted (3D echo-spoiled gradient echo; TR, 27 ms; TE, 6 ms; number of acquisitions, 1; image resolution, 0.94 × 0.94 × 1.6 mm³) and T2-weighted (fast spin-echo; TR, 8060 ms; TE, 104 ms; number of acquisitions, 2; image resolution, 0.51 × 0.51 × 4.0 mm³) images were acquired. DTI was measured using a diffusion-weighted, single-shot, echo-planar imaging (EPI) sequence, with an image size of 128 × 128 and an in-plane resolution of 2 × 2 mm². The whole brain was covered with 38 contiguous axial sections at a section thickness of 3 mm. The TR and TE were 6.5 seconds and 80 ms, respectively. A noise-optimized diffusion encoding schema with 55 diffusion encoding directions was used.^19,20 The b factor was 1000 s/mm², and 5 b0 images were measured.

Calibration of DTI measurements was done on a water phantom. We defined the ADC as the trace of the diffusion tensor (D′), equivalent to the ADC of isotropic media. ADCs were compared with temperature-corrected literature data.²¹ Diffusion tensor maps were calculated pixel-by-pixel using custom software on the MATLAB platform (The Mathworks, Natick, Mass). ADC and FA were estimated in deep gray matter (ie, in caudate nucleus, lentiform nucleus [putamen and globus pallidus], and thalamus) and in WM (parietooccipital, frontal), pons, and corpus callosum (Fig 1). To avoid partial volume effects, regions of interest (ROIs) were selected pixel-by-pixel based on ADC, FA, and b0 images rather than using predefined ROIs. All ROIs for patients and control subjects were selected by the same investigator (S.L.Z.) individually based on anatomic landmarks in each subject. The ROIs from the corpus callosum were only chosen in a single plane to avoid partial volume effects. High-resolution T1- and T2-weighted MR images were used as references, but ROI selection was done on the ADC, FA, and b0-images to avoid misregistration between EPI and high-resolution images caused by the intrinsic susceptibility sensitivity of EPI.

• Download figure
• Open in new tab
• Download powerpoint

Fig 1.

Images of a 20-year-old woman with NF-1. Axial B₀ images showing the pixel-wise chosen ROIs framed in red: caudate nucleus, thalamus, lentiform nucleus (putamen and globus pallidus) (left), frontal WM (middle), and parietooccipital WM (right).

Statistical Procedure.

Statistical analyses were performed using SPSS version 11.5.1 (SPSS, Chicago, Ill). Mean ROI ADC and FA values of the different brain areas were analyzed separately in a multivariate analysis of variance with the between subject factor “group” (“patients with NF-1” and “healthy volunteers”). The within-group age dependence of ADC and FA values was tested separately for each region of interest by using a nonparametric bivariate correlation analysis (Kendall τ-b and Spearman). A paired t test was performed on all bilaterally measured ROI ADC and FA values to test for hemispheric differences within the groups.

Results

Discussion

Elevated ADC and decreased FA values were found in every investigated anatomic brain location of patients with NF-1 compared with the age-matched control subjects (P < .001). We could corroborate the findings of former studies concerning the elevated ADC. Alkan et al²² found elevated ADC values in NBO and in some normal-appearing regions (hippocampus and thalamus), whereas Eastwood et al²³ revealed elevated ADC values in hyperintense lesions as well as in normal-appearing basal ganglia compared with the control group. In a longitudinal study Sheikh et al also found increased ADC values in NBOs.²⁴

Moreover, diffusion-weighted imaging (DWI) and DTI have successfully been applied to detect microstructural changes in patients with different brain disorders. Ashtari et al²⁵ reported decreased FA values in several brain regions (normal-appearing WM: frontal, parietal, temporal, occipital, splenium of the corpus callosum, posterior limb of the internal capsule, and WM lesions frontal and parietal) of patients with attention-deficit/hyperactivity disorder. Fukuda et al²⁶ investigated patients with myotonic dystrophy and described lower FA values in the cerebral WM of the patients compared with healthy control subjects.

Although Alkan et al,²² Eastwood et al,²³ and Sheikh et al²⁴ did not determine FA in their NF-1 patient groups, our study revealed reduced FA values in all selected ROIs and in all patients. Our results indicate microstructural changes of brain tissue. A reduction in FA and an increase in ADC might indicate a disintegration of the myelin sheaths and/or an axonal disruption.²⁷ The observed increase in diffusion in the brains of patients with NF-1 may originate from a myelin disorder, such as an intramyelinic edema.¹⁶ Sheikh et al²⁴ explained their findings as a result of increased number and/or size of myelin vacuoles. On the other hand Alkan et al²² saw their results in the context of a possible demyelination. Eastwood et al²³ also explained it as demyelination or “as myelin disturbance, such as diminished myelin amount or increased myelin turnover.”

Using DWI, Tognini et al²⁸ found increased ADCs in normal-appearing brain as well as in regressed NBO. DiPaolo et al¹⁶ did not observe a “frank demyelination” in their histopathologic findings of NBOs in 3 patients with NF-1. Instead, they reported a spongiform myelinopathy or a vacuolar change of myelin. To our knowledge, this is the only realized histopathologic investigation into hyperintense lesions in patients with NF-1. These findings, however, may not be truly representative for the entire NF-1 population, because 2 of their patients had severe clinical symptoms: 1 was a premature baby with an intraventricular hemorrhage and seizures, and the other received chemotherapy for treatment of fibrosarcoma. Only the 3rd patient, who died as a result of complications during a scoliosis surgery, seemed to represent the “usual” NF-1 patient without comorbidity. Nevertheless, DiPaolo et al reported identical histopathologic findings in all 3 patients.

One could speculate that the alterations of ADC and FA in patients with NF-1 reported here might have originated from globally increased brain water. However, the only existing histologic study in patients with NF-1¹⁶ reported no conspicuousness concerning the brain water content in these patients but did report a spongiform myelinopathy or a vacuolar change of myelin. Notwithstanding these findings, we cannot exclude globally increased brain water as the reason for the altered ADC and FA values in NF-1 patients. However, the observed alterations in brain diffusion are more likely to indicate a dismyelination in patients with NF-1.

In many NF clinics neuroimaging is not considered an essential investigation at initial presentation of a patient with NF-1 who has normal neurologic states, including vision. Therefore, no previous MR imaging is available in our patient group. Thus, whether they had NBOs in some of the investigated regions during childhood is not known. Alkan et al²² reported significantly increased ADCs in normal-appearing hippocampus and thalamus on T2-weighted images, which they considered residual lesions from former NBOs. Based on these reports, it seems to be very unlikely that our ADC changes in each of the examined brain areas originate from such residual lesions.

The great variability of FA and ADC values of P6 with ventricular dilation, which were outside the normative confidence intervals, might be explained by partial volume effects between brain tissue and CSF.

Sheikh et al²⁴ examined 12 patients with NF-1 between 2–20 years. They speculated that ADCs may approach more near-normal values with increasing age. Nevertheless, the data presented in their Fig 2 depict ADC values in adult patients with NF-1 that are higher than in the age-matched control subjects, which corresponds well to our findings.

Although Alkan et al,²² Sheikh et al,²⁴ and Tognini et al²⁸ reported similar alterations of ADC, a quantitative comparison with the results reported in this study is not appropriate because of methodologic dissimilarities and differences in the examined age range of patients with NF-1.

We did not observe any age dependency in our adult patients, which accords closely with findings of Snook et al²⁹ and may be explained by the completed myelination process in adult brains. Longitudinal measurements from childhood to adulthood would be required to answer the question of whether there is a recovery of altered myelination in patients with NF-1.

Few data have been published on hemispheric differences in patients with NF-1. Eastwood et al²³ did not observe significant ADC variations between hemispheres, except for the thalamus. Our data revealed hemispheric ADC differences in caudate, thalamus, and WM (parietooccipital and frontal), but no global left-right tendency was found. We did not detect hemispheric differences in FA, except in the parietooccipital WM. Although we have not performed neuropsychologic testing in our patients, it is remarkable that identical findings were obtained in university graduates and in patients who attended special school.

Conclusion

We found elevated ADC and decreased FA values in all selected brain regions of all patients with NF-1 compared with age-matched healthy volunteers. We interpret our findings to be a consequence of diffuse and basic alterations in cerebral microstructure in the mature NF brain, resulting from the underlying gene mutation.